Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
GlaxoSmithKline
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
Amgen
Eli Lilly and Company
Hoffmann-La Roche
Pfizer
Pfizer
SWOG Cancer Research Network
Merck Sharp & Dohme LLC
AstraZeneca
ArriVent BioPharma, Inc.
Achieve Life Sciences
Boehringer Ingelheim
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
George Washington University
Genmab
Alliance for Clinical Trials in Oncology
Taiho Oncology, Inc.
NRG Oncology
NRG Oncology
NRG Oncology
NRG Oncology
Merck Sharp & Dohme LLC
Vergent Bioscience, Inc.
Nuvalent Inc.
M.D. Anderson Cancer Center
Seagen Inc.
Revolution Medicines, Inc.
Hoffmann-La Roche
City of Hope Medical Center
Merck Sharp & Dohme LLC
BioNTech SE
Roswell Park Cancer Institute
EMD Serono
Ottawa Hospital Research Institute
AstraZeneca